Distinguished member of the Société Chimique de France since 2019, Dr Ling Peng, also CNRS research director at the Centre Interdisciplinaire de Nanoscience de Marseille (CNRS/AMU), is the winner of the Grand Prix SCF Sud PACA 2024.
Reading time: 2 minutes
Work at the interface of chemistry and biology
Since joining the CNRS in 1997, Dr. Peng's research has been carried out at the interface of chemistry and biology, and is mainly devoted to the development of chemical probes for understanding biological events, the discovery of bioactive molecules and biomedical applications based on dendrimer nanotechnology. With her team, she is developing small molecules with antiviral, anticancer and antibacterial properties as drug candidates, and molecular probes to study and understand the roles and signaling pathways of Krebs cycle intermediates in nitrogen fixation and cancer development.
A new concept in dendrimer production
Recently, she has been actively developing multifunctional dendrimers as smart nanomaterials for biomedical applications. Dendrimers are synthetic molecules, manufactured by chemists, and shaped like the branches of a tree. Their properties are being studied by researchers all over the world.
Dr Peng recently inaugurated a new concept of dendrimer fabrication by self-assembly to create supramolecular dendrimers for drug and gene delivery, and imaging agents for cancer detection and treatment. This concept opens up a new direction in the molecular engineering of functional materials.
A research team accredited by the French League against Cancer
The originality and quality of Dr Peng's work have earned her numerous national and European funding awards, and she is co-author of over 160 international publications and seven patents. Her "Biomolecules and Biomaterials" research team at the Centre Interdisciplinaire de Nanoscience de Marseille, has been certified by the Ligue contre le Cancer since 2016.
Article published on February 23, 2024.
Discover also
Share on social media or
